Effectiveness and cost-effectiveness of a novel, group self-management course for adults with chronic musculoskeletal pain: study protocol for a multicentre, randomised controlled trial (COPERS)

被引:9
作者
Carnes, Dawn [1 ]
Taylor, Stephanie J. C. [1 ]
Homer, Kate [1 ]
Eldridge, Sandra [2 ]
Bremner, Stephen [1 ]
Pincus, Tamar [2 ]
Rahman, Anisur [3 ]
Underwood, Martin [4 ]
机构
[1] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Primary Care & Publ Hlth, London, England
[2] Royal Holloway Univ London, Dept Psychol, London, England
[3] Univ Coll London Hosp, Dept Rheumatol, London, England
[4] Univ Warwick, Warwick Med Sch, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England
基金
美国国家卫生研究院;
关键词
BACK-PAIN; INTERVENTIONS; QUESTIONNAIRE; EDUCATION; EFFICACY; OUTCOMES; PROGRAM; ANXIETY;
D O I
10.1136/bmjopen-2012-002492
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Chronic musculoskeletal pain is a common condition that often responds poorly to treatment. Self-management courses have been advocated as a non-drug pain management technique, although evidence for their effectiveness is equivocal. We designed and piloted a self-management course based on evidence for effectiveness for specific course components and characteristics. Methods/analysis: COPERS (coping with persistent pain, effectiveness research into self-management) is a pragmatic randomised controlled trial testing the effectiveness and cost-effectiveness of an intensive, group, cognitive behavioural-based, theoretically informed and manualised self-management course for chronic pain patients against a control of best usual care: a pain education booklet and a relaxation CD. The course lasts for 15 h, spread over 3 days, with a -2 h follow-up session 2 weeks later. We aim to recruit 685 participants with chronic musculoskeletal pain from primary, intermediate and secondary care services in two UK regions. The study is powered to show a standardised mean difference of 0.3 in the primary outcome, pain-related disability. Secondary outcomes include generic health-related quality of life, healthcare utilisation, pain self-efficacy, coping, depression, anxiety and social engagement. Outcomes are measured at 6 and 12 months postrandomisation. Pain self-efficacy is measured at 3 months to assess whether change mediates clinical effect. Ethics/dissemination: Ethics approval was given by Cambridgeshire Ethics 11/EE/046. This trial will provide robust data on the effectiveness and cost-effectiveness of an evidence-based, group self-management programme for chronic musculoskeletal pain. The published outcomes will help to inform future policy and practice around such self-management courses, both nationally and internationally.
引用
收藏
页数:10
相关论文
共 59 条
[1]  
Ajzen I, 1976, ADDISON WESLEY SERIE
[2]  
Ajzen I., 1980, Understanding attitudes and predicting social behavior
[3]  
[Anonymous], 150 YEARS ANN REPORT
[4]  
[Anonymous], PAIN
[5]  
[Anonymous], 1995, COGNITIVE THERAPY
[6]  
[Anonymous], 2001, EXP PAT NEW APPR CHR
[7]  
[Anonymous], 2014, R LANG ENV STAT COMP
[8]  
[Anonymous], 2011, CENS 2011
[9]  
[Anonymous], 2007, STAT STAT SOFTW REL
[10]  
[Anonymous], 2002, PSYCHOL APPROACHES P